Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

NUP210 antibody (N-Term) (PE)

This anti-NUP210 antibody is a Rabbit Polyclonal antibody detecting NUP210 in WB, IHC, ELISA and FACS. Suitable for Human.
Catalog No. ABIN2316504

Quick Overview for NUP210 antibody (N-Term) (PE) (ABIN2316504)

Target

See all NUP210 Antibodies
NUP210 (Nucleoporin 210kDa (NUP210))

Reactivity

  • 46
  • 14
  • 12
Human

Host

  • 49
Rabbit

Clonality

  • 49
Polyclonal

Conjugate

  • 19
  • 4
  • 4
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This NUP210 antibody is conjugated to PE

Application

  • 37
  • 19
  • 17
  • 13
  • 13
  • 11
  • 8
  • 7
  • 7
  • 3
  • 2
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Flow Cytometry (FACS)
  • Binding Specificity

    • 15
    • 8
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    AA 209-239, N-Term

    Cross-Reactivity

    Human

    Cross-Reactivity (Details)

    Calculated cross reactivity: Hu

    Characteristics

    NUP210, NT (NUP210, KIAA0906, Nuclear pore membrane glycoprotein 210, Nuclear envelope pore membrane protein POM 210, Nucleoporin Nup210, Pore membrane protein of 210kD) (PE)

    Purification

    Purified by Protein A affinity chromatography.

    Immunogen

    NUP210 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 209~239 amino acids from the N-terminal region of human NUP210.

    Isotype

    IgG
  • Application Notes

    Optimal working conditions should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Supplied as a liquid in PBS, pH 7.2.

    Storage

    4 °C

    Storage Comment

    4°C ,Do Not Freeze
  • Target

    NUP210 (Nucleoporin 210kDa (NUP210))

    Alternative Name

    NUP210

    UniProt

    Q8TEM1

    Pathways

    SARS-CoV-2 Protein Interactome, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
You are here:
Chat with us!